![]() |
![]() |
|
|
||
![]() |
MFIII HP Injectibles
MFIII Human Placenta (HP 230mg per Vial)NEW 2009 PRICE!!! Reduced by 40%!! Recent scientific research has shown human placenta contains rich growth factors, hormones, proteins, glycosaminoglycans, nucleic acids, polydeoxyribonucleotides (PDRNs), antibodies, and other concentrated nutrients that can rejuvenate organic tissue. It is rich in over 128 growth factors including HGF, NGF, EGF, FGF, CFS, IGF-1, TGF, IL1, IL2, IL3 and IL4. Mitogenic actions of cytokines from placenta show an array of physiological effects – anti-inflammatory, regulation of autonomous nerve system, improvement of circulation, wound tissue healing, inhibition of protease, enhancement of nerve regeneration, balancing multiple hormone levels, immune boosting (anti-allergic), analgesic effect and the improvement of intestinal environment. Placenta HP is a safe therapeutic agent with potent regenerating activities on all human tissue. When introduced into humans (internally), it can reinforce deteriorating cells and hence bring back or restore their youth. Composition of MFIII HP 230MFIII of Switzerland HP 230mg contains highly concentrated Placenta prepared using a patented high-tech extraction technology utilizing ultra-filtration. Extraction is a common pharmaceutical technology used to isolate peptides, proteins, enzymes or cytokines, growth factors, hormones, and other compounds which are essential substances for aging or ill organisms. The extraction and processing of tissue is done without denaturing heat sterilization nor any chemical additives. Properties of MFIII HP 230MFIII of Switzerland HP 230mg, with its active and specific components (peptides, proteins, enzymes, cytokines, hormones, growth factors and others), works as a substitute for aging and ill people whose cellular regeneration process has deteriorated. This substitution may lead to restoration or regeneration and revitalization.
Benefits of MFIII HP 230As a therapy for revitalization and rejuvenation MFIII HP has a number of benefits aside from managing the effects of aging. Some examples are:
DosageFor a generally healthy person:Purpose of injection: Anti-aging, disease prevention. Regular cycle: 1-2 vials per week or even 1 vial every 2 weeks There is no overdosage so you can increase dosage without worrying about any risk. Note: As with any injection, minor swelling may occur at the injection site on your skin. For a person who has a particular ailment or injury:Depending on the individual, a complete 50 vial treatment 5-7 days a week, or even 2 vials every other day is recommended. For sensitive patients you can reduce the number of treatments to 1 or 2 vials each time in daily or alternate days with a maximum of 12 vials each week. There is no over dosage for our placenta extracts. Excess will pass harmlessly through the body A repetition of the treatment cycle after 6 and 12 months is possible depending on the illness and the individual patient's health. A deep, subcutaneous or intramuscular injection on the Gluteal area with a thin needle should be given. Swiss Authorities CertificationMFIII is vigoously tested in independent Swiss laboratories and carries Swiss Certification number SCES002023. MFIII is originally manufactured and packed in Switzerland with full conformity to international stringent standards of the following:
Safety and Effectiveness of MFIII HP 230A number of studies have been conducted to ensure the safety of MFIII HP 230. Decades of clinical experience also demonstrate the safety and effectiveness of placenta therapy. Placenta HP is a safe therapeutic agent with the potential to regenerate activity within all human tissue. When introduced into the humans internally, it can reinforce deteriorating cells and lower cellular age. It has been demonstated as an unparalleled anti-aging and health agent MFIII HP 230 is a very unusual Human placenta product because it uses an ultrafiltration method for sterilization rather than a heat-treatment like most other placenta based products. Other inferior methods use temperatures of 125-180 degrees Celsius to cheaply sterilize human placenta, but this results in damaging or destroying many of the most effective elements. MFIII holds itself to the highest standards of safety the final product is tested for Hepatitis, HIV and undergoes ELISA testing. Donors are also pre-screened and placenta from eligible donors in the European Union are collected at Government approved hospitals only. Donors suffering from communicable diseases, Hepatitis, HIV, Breech delivery, Twins birth, under weight birth, and Burns are not considered. In some cases reddening and swelling may occur at the injection site like with any type of injection. A cold compress can be applied and a gentle application of a heparin ointment to cool the area should be sufficient to reduce redness. Storage Do not expose to heat or sunlight. Keep out of reach of children. Best kept under refrigeration but not freezing conditions. Research & Formulated by: Manufactured by: Lab Dom Avmm, Switzerland Note: |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Shipping | Effects of MFIII | Manufacturer of MFIII | MFIII-Customer's Voice | Certification of MFIII | About us | Links | Contact us | |